Divis Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 2,623 | 2,379 | 2,407 |
| Operating Expense | 1,655 | 1,550 | 1,573 |
| Net Profit | 667 | 594 | 518 |
| Net Profit Margin | 25.43 | 24.97 | 21.52 |
| Earning Per Share | 25.12 | 22.39 | 19.51 |
| EBIDTA | 999 | 865 | 835 |
| Effective Tax Rate | 23.24 | 20.75 | 26.14 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 2623.00 |
| Operating Expense | 1655.00 |
| Net Profit | 667.00 |
| Net Profit Margin | 25.43 |
| Earning Per Share | 25.12 |
| EBIDTA | 999.00 |
| Effective Tax Rate | 23.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 9,198 | 7,665 | 7,625 |
| Operating Expenses Annual | 6,219 | 5,491 | 5,277 |
| Operating Profit Annual | 3,331 | 2,511 | 2,697 |
| Interest Annual | 1 | 3 | 1 |
| Depreciation | 398 | 373 | 338 |
| Net Profit Annual | 2,209 | 1,576 | 1,808 |
| Tax Annual | 720 | 556 | 546 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 9,198 |
| Operating Expenses Annual | 6,219 |
| Operating Profit Annual | 3,331 |
| Interest Annual | 1 |
| Depreciation | 398 |
| Net Profit Annual | 2,209 |
| Tax Annual | 720 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 344 | 144 | 1,200 |
| Cash Flow from Operations | 1,650 | 1,266 | 2,447 |
| Cash Flow from Investing | -803 | -268 | -2,707 |
| Cash Flow from Financing | -797 | -798 | -796 |
| Cash Flow at the End | 394 | 344 | 144 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 344 |
| Cash Flow from Operations | 1,650 |
| Cash Flow from Investing | -803 |
| Cash Flow from Financing | -797 |
| Cash Flow at the End | 394 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 36.23 | 32.77 | 35.38 |
| PBIT Margin (%) | 31.87 | 27.87 | 30.90 |
| PBT Margin (%) | 15.94 | 20.90 | 15.45 |
| Net PROFIT Margin (%) | 24.02 | 20.56 | 23.71 |
| Return On Networth / Equity (%) | 15.57 | 12.04 | 14.82 |
| Return On Networth /Employed (%) | 20.63 | 16.27 | 19.27 |
| Return On Assets (%) | 15.61 | 11.93 | 14.70 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.65 | 0.58 | 0.62 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 36.23 |
| PBIT Margin (%) | 31.87 |
| PBT Margin (%) | 15.94 |
| Net PROFIT Margin (%) | 24.02 |
| Return On Networth / Equity (%) | 15.57 |
| Return On Networth /Employed (%) | 20.63 |
| Return On Assets (%) | 15.61 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.65 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 5,440 | 4,737 | 4,719 |
| Total Current Assets Annual | 9,979 | 9,572 | 9,236 |
| Non Current Assets Annual | 6,845 | 5,790 | 5,116 |
| Total Shareholders Funds Annual | 14,895 | 13,484 | 12,705 |
| Total Assets Annual | 16,824 | 15,362 | 14,352 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 5,440 |
| Total Current Assets Annual | 9,979 |
| Non Current Assets Annual | 6,845 |
| Total Shareholders Funds Annual | 14,895 |
| Total Assets Annual | 16,824 |
EPS (INR)
Expected
24.98
Reported
24.93
Surprise
-0.20%
Dec 2024
EPS beaten by -0.20%
Sep 2024
EPS beaten by -0.13%
Jun 2024
EPS beaten by -0.26%
